Oak Longevity vs Maximus: Low-Cost Compounded GLP-1 Options
Quick verdict: Oak Longevity vs Maximus
Oak Longevity and Maximus are both low-cost telehealth options for compounded GLP-1 semaglutide programs. Oak emphasizes one flat price for all dosages, no subscriptions, free health coaching, and an asynchronous clinician review. Maximus offers a similar low monthly rate for semaglutide at $132.99/month with prescriptions approved by licensed doctors and filled through trusted U.S. pharmacies. Early verdict: choose Oak if you want flat pricing, no subscription billing, and free coaching; choose Maximus if you prioritize prescriptions filled via U.S. pharmacies and a traditional telemedicine workflow.
See Oak Longevity pricing and start
Top differences at a glance
The most distinctive differences between Oak Longevity and Maximus are pricing structure and drug variety, clinical review method, pharmacy sourcing and shipping, and included services like health coaching. Both offer compounded medications; both note that compounded medications are not FDA approved finished products.
| Criteria | Oak Longevity | Maximus |
|---|---|---|
| Starting price | $133/mo semaglutide; $199/mo tirzepatide | $132.99/mo semaglutide |
| Tirzepatide availability | Offers tirzepatide from $199/mo | No clear published tirzepatide details supplied |
| Clinical review method | Asynchronous licensed clinician review, no video call required | Telemedicine access with licensed doctors reviewing cases |
| Pharmacy and shipping | Free shipping with tracking included | Filled through trusted U.S. pharmacies with free expedited shipping |
| Billing and subscriptions | No subscriptions, billed monthly on a non recurring basis; three month prescriptions billed upfront | Direct pay with transparent pricing and no membership fees |
| Included services | Free health coaching included | No coaching noted in supplied facts |
| Regulatory note | Compounded medications are not FDA approved finished products | Compounded medication only; not FDA approved finished products |
Pricing and value
Both providers list low flat rates for semaglutide with Oak quoting semaglutide from $133/month and tirzepatide from $199/month while Maximus lists semaglutide at $132.99/month. Oak highlights a one price covers all dosages approach. Maximus emphasizes a low flat rate and a straightforward direct pay model. The supplied facts do not provide additional long term pricing guarantees or insurance billing details.
Clinical workflow and pharmacy sourcing
Oak uses an asynchronous clinician review process with no video call required and notes board certified physicians in your state review cases. Maximus provides telemedicine access where licensed doctors approve prescriptions and medications are filled through trusted U.S. pharmacies. If pharmacy sourcing or a synchronous telemedicine visit matters to you, Maximus documents U.S. pharmacy fulfillment while Oak documents asynchronous review and same day approval availability for qualifying patients.
Services, shipping, and program limits
Oak explicitly includes free health coaching and free shipping with tracking and states three month prescriptions are billed upfront and no refunds are available after physician approval and once medication has shipped. Maximus lists free expedited or priority shipping and states that if you are not approved for treatment your medication costs will be fully refunded. Oak also notes patients with BMI below 20 do not qualify for GLP 1 treatment and that treatment is available only when a licensed clinician determines it is medically appropriate.
Check Oak Longevity availability
Safety and regulatory status
Both sources state the medications offered are compounded and that compounded medications are not FDA approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality. Oak explicitly states compounded medications, when offered, are not FDA approved and reiterates treatment is available only when a licensed clinician determines it is medically appropriate. Maximus also notes compounded medication only, not an FDA approved finished product.
Oak Longevity vs Maximus: final thoughts
Oak Longevity and Maximus both serve cost conscious patients seeking compounded semaglutide through telehealth. Oak pairs low published prices with one flat price for all dosages, free health coaching, free shipping, and an asynchronous clinical review. Maximus offers a comparable semaglutide price at $132.99/month, telemedicine with licensed doctors, and fulfillment through trusted U.S. pharmacies with expedited shipping and a refund if not approved. The primary keyword Oak Longevity vs Maximus summarizes these trade offs.
Choose one if
Choose Oak Longevity if you want a one price all dosages approach, free health coaching and free shipping, no subscription billing, and asynchronous clinician review.
Choose Maximus if you prefer prescriptions approved via telemedicine and filled through trusted U.S. pharmacies with documented expedited shipping and a $132.99/month semaglutide rate.